Process for the isolation of a major harmful oxidant from cigarette smoke
AssigneeCouncil of Scientific and Industrial Research
InventorIndu Bhusan Chatterjee
Life of this patent
Estimating the term…
Loading patent…
AssigneeCouncil of Scientific and Industrial Research
InventorIndu Bhusan Chatterjee
Estimating the term…
The components of cigarette smoke, known until now, do not explain the overwhelming hazardous effects of smoking; this invention describes the isolation, identification and procedures for determination of the structure, properties and assay of a relatively stable major harmful oxidant (cs-oxidant) present in the cigarette smoke, the content of which is about 190±10 μg per cigarette; the cs-oxidant alone almost quantitatively accounts for the oxidative damage of proteins produced by the aqueous extract of whole cigarette smoke, it is also responsible for the oxidative damage of DNA; since the cs-oxidant is relatively stable, it further explains the deleterious effects of the side stream smoke and passive smoking; a number of chemical compounds/agents including vitamin C have been found to prevent the cs-oxidant induced protein oxidation in vitro.
A process for the isolation of p-benzosemiquinone of formula 1
A process for the quantitative determination of p-benzosemiquinone of formula 1, a major harmful oxidant isolated from cigarette smoke responsible for the oxidative damage of proteins and DNA, the said process comprising the steps of
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Investigating or analysing non-biological materials by the use of the chemical methods
Antineoplastic agents
General protective or antinoxious agents: antidotes
Investigating or analysing materials by determining their chemical or physical properties
Term ended 31 Aug 2022 (estimated)
The present invention relates to a process for the isolation of p-benzosemiquinone of formula 1:
a major harmful oxidant from cigarette smoke. More particularly the present invention provides a process for the isolation of p-benzosemiquinone, a major harmful oxidant from cigarette smoke, which is responsible for the oxidative damage of proteins and DNA
Exposure to cigarette smoke is a major cause of life-threatening diseases like bronchitis, emphysema, other diseases of the respiratory tract, coronary heart diseases, lung cancer and other malignancies [1-5]. In fact, cigarette smoke is the overwhelming cause of lung cancer, now the most common cancer globally. Since approaches to cessation of smoking by public health campaigns and anti-smoking laws passed by local Governments have had limited success, the most practicable approach is the prevention of the hazardous effects caused by cigarette smoke. Cigarette smoke in known to contain about 4000 components, out of which about 3000 components are present in the gas phase and about 1000 components in the tar phase [6]. The oxidants in the gas phase, such as O2−, H2O2, NO, peroxy radical are extremely unstable [7]. If the gas phase is passed into phosphate buffer and the resultant solution is added to albumin solution, no protein oxidation occurs (7). Apparently, any damage caused by the gas phase is expected to be restricted to the buccal cavity and upper respiratory tract [8]. On the other hand, the oxidant(s) present in the tar are quite stable and these are apparently responsible for producing oxidative damage in the lung, heart and other organs [7,9]. About 48 percent of the tar components are water soluble [10] and the aqueous extract of tar is known to produce oxidative damage of biological macromolecules including proteins and DNA [7,11,12]. However, it is perplexing to conceive how many of the components present in the aqueous extract of tar are responsible for producing oxidative damage in the biological system. Uptil now, among the many components of cigarette smoke, three classes of compounds have been suggested to be implicated as causative agents in the development of cancer and degenerative diseases, namely, (i) polycyclic aromatic hydrocarbons (ii) nitrosamines and (iii) free radicals.
FIG. 1 shows Mesomeric forms of p-benzosemiquinone, a) anionic, b) and c) neutral and d) cationic;
FIG. 2 Band thin layer chromatography of the methanol solution after lyophilization—indicates the band of the cs-oxidant
FIG. 3 HPLC profile of the butanol extract after TLC The cs-oxidant (step 6) eluted as a major peak at the retention time of 8.808 min. The amount of cs-oxidant eluted was ˜12 μg.
Table 1. Estimation of oxidative potency at different stages of purification of the cs-oxidant
Table 2. Oxidation of ascorbic acid by the cs-oxidant as measured by HPLC analysis
Table 3. BSA oxidation by fractions of CS-solution at different stages of purification